HomeBusiness NewsThis Australian biotech could more than double in value

This Australian biotech could more than double in value

September 2, 2025

- Advertisement -

Image source: Getty Images

Biotechs can be a risky investment, but where the risks are high, so potentially are the gains. Wilsons Advisory forecasts more than 100% upside for PYC Therapeutics Ltd (ASX: PYC).

PYC, which is valued at about $720m, is developing a drug candidate, PYC-003, which…

Click here to view the original article.

Tags
Fool.com.au

- Advertisment -

Breach of undertaking earns reprimand, fine – Proctor

Bay Ten Espresso, Lavender Bay Review

This Australian biotech could more than double in value

Recently Viewed

Regis Resources reports fatal accident at Duketon South gold operation in Western Australia

Widow slams false Hamas claim against Gaza journalist

Access Canberra ticks off Big Splash’s makeshift ‘restaurant’ despite packing up shop in less than a day

2026 midterm results: What a Democratic Congress could mean for Trump’s Cabinet

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

Olivia Hargroder, a dancer with Down syndrome, survived heart surgery at nine weeks old after doctors gave her just a 20% chance of survival....

Teen charged by counter-terror police over alleged plot to kill

Aston Martin and Glenfiddich Join Forces on Glenfiddich 28 Years Old

POPULAR CATEGORY

FOLLOW US

This Australian biotech could more than double in value

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US